Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Topiramate Effects on Cognition and Language
NCT01889602Phase 4Completed
- Sponsor
- University of Minnesota
- Start
- Jul 2013
- Primary completion
- Aug 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of topiramate in epilepsy, migraine, obesity, pain, sponsored by University of Minnesota. Started Jul 2013; status: completed.
02
Drugs
topiramate
03
Conditions
epilepsymigraineobesitypain
Beyond the preview
Go deeper on NCT01889602.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01889602.